Craniopharyngioma clinical trials

The registry lists 76 studies for Craniopharyngioma across more than 10 countries. 19 are recruiting or about to start. 35 of them are mainly about Craniopharyngioma (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21.

Get an email when these change. Save the Craniopharyngioma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 38
Recruiting: 13
Active, not recruiting: 8
Status unknown: 5
Not yet recruiting: 4
Withdrawn: 3

Phase

Phase 2: 23
Phase 1: 17
Phase 3: 6
Early Phase 1: 2
Phase 4: 2

Where

United States: 43
China: 9
France: 7
Australia: 5
Germany: 4
Canada: 3

Who runs them

St. Jude Children's Research Hospital (5) · West China Hospital (3) · Wake Forest University Health Sciences (3) · Assistance Publique - Hôpitaux de Paris (3) · National Institutes of Health Clinical Center (CC) (3) · Klinikum Oldenburg gGmbH (2) · University of Colorado, Denver (2) · National Cancer Institute (NCI) (2)

What is being tested here

Drugs under test in Craniopharyngioma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Tocilizumab	1	0	2
Deamino Arginine Vasopressin	1	0	1
Semaglutide	1	1	1
Tovorafenib	1	0	1
Binimetinib	1	0	1
Anlotinib	1	0	1
Liraglutide	1	0	1
Exenatide	0	1	3
Donepezil	0	1	2
Qsymia	0	0	1

Drug classes tested here GLP-1 receptor agonists 2 open

Coming up

1phase 3 study under way

8studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8

Dec 2026Long-Term Longitudinal QoL in Patients Undergoing EEA · Ohio State University
Dec 2026Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery · West China Hospital
Dec 2026ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients · Deling Li
Mar 2027Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults · Sabine Mueller, MD, PhD
Apr 2027FOG-001 in Locally Advanced or Metastatic Solid Tumors · Parabilis Medicines, Inc.
Apr 2027MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma · Nationwide Children's Hospital
Jul 2027Methionine PET/CT Studies In Patients With Cancer · St. Jude Children's Research Hospital
Sep 2027Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma · Eva Marie Erfurth, MD, PhD

Who these studies take

Of the 13 Craniopharyngioma studies recruiting now, 5 (38%) set no upper age limit and 7 (54%) stop at 75 or younger. 5 (38%) take children under 18. 1 (8%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 13
Age	Women	Men
10	4 (31%)	4 (31%)
18	12 (92%)	11 (85%)
30	12 (92%)	11 (85%)
40	9 (69%)	8 (62%)
50	9 (69%)	8 (62%)
65	9 (69%)	8 (62%)
75	8 (62%)	7 (54%)
85	5 (38%)	4 (31%)

Across all 76 studies, recruiting or not: 55% stop at 75 or younger and 39% at 65; 42% take children; 1% are for women only and 1% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 76. Browse all 76 → or search them.